BACCI: A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Capecitabine Bevacizumab Plus Atezolizumab Versus Capecitabine Bevacizumab Plus Placebo in Patients With Refractory Metastatic Colorectal Cancer
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab; Capecitabine
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms BACCI
- 24 Mar 2017 Planned initiation date changed from 1 Mar 2017 to 1 Apr 2017.
- 24 Jan 2017 Planned initiation date changed from 1 Oct 2016 to 1 Mar 2017.
- 26 Sep 2016 Planned initiation date changed from 1 Aug 2016 to 1 Oct 2016.